HomeSNOA • NASDAQ
add
Sonoma Pharmaceuticals Inc
Previous close
$2.87
Day range
$2.86 - $2.86
Year range
$1.75 - $9.37
Market cap
4.70M USD
Avg Volume
44.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 3.75M | 9.16% |
Operating expense | 2.18M | -12.64% |
Net income | -776.00K | 27.27% |
Net profit margin | -20.67 | 33.39% |
Earnings per share | — | — |
EBITDA | -625.00K | 54.31% |
Effective tax rate | -46.97% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.37M | 71.80% |
Total assets | 13.69M | -7.10% |
Total liabilities | 9.28M | 7.89% |
Total equity | 4.41M | — |
Shares outstanding | 1.64M | — |
Price to book | 1.06 | — |
Return on assets | -11.99% | — |
Return on capital | -33.80% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -776.00K | 27.27% |
Cash from operations | -95.00K | -162.50% |
Cash from investing | -47.00K | -361.11% |
Cash from financing | 242.00K | -61.09% |
Net change in cash | 138.00K | -80.89% |
Free cash flow | -261.00K | -195.82% |
About
Founded
1999
Headquarters
Website
Employees
168